Caribou Biosciences (CRBU)Chief Business Officer sold ~$14K

~$14K

Approx. value · 6,938 sh @ $1.96

105K

Holds after · shares reported

Traded

Feb 24, 2026

Filed

Feb 25, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 24, 2026 · this disclosureInsiderOfficer sold ~$14K of CRBU shares in the open market

What came next

1. Feb 24, 2026Insider · 3 peopleInsiders: 3 sales (~$22K)
2. Feb 25, 2026InsiderOfficer sold ~$12K of CRBU shares in the open market
3. Mar 5, 2026Company filing · Form 8-K · ResultsReported its results
4. May 7, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Caribou Biosciences

OQRO holds no insider, Congress, fund or contract record for Caribou Biosciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRBU page.

Other recent filings by Ruhi Ahmad Khan, Chief Business Officer

• SEC Form 4 at Caribou Biosciences (CRBU)Feb 22, 2025

The full history of Ruhi Ahmad Khan, Chief Business Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Caribou Biosciences

• SEC Form 4Feb 28, 2026
• SEC Form 4Feb 25, 2026
• SEC Form 4Feb 25, 2026
• SEC Form 4Feb 25, 2026
• SEC Form 4Mar 17, 2025
• SEC Form 4Feb 22, 2025

Everything OQRO holds on this company is on its CRBU page.